Use of Continuous Intravenous Anakinra Infusion in Multisystem Inflammatory Syndrome in Children
Coronavirus disease (COVID-19) is an emergency pandemic with a high mortality rate worldwide. One of its complications in children is developing multisystemic inflammatory syndrome related to cytokine storm. Anakinra is a recombinant human interleukin-1 (IL-1) receptor antagonist used to suppress th...
Saved in:
Main Authors: | Abdulaziz Alolayan, Abdullah S. Aldamegh, Azzah Alkhayrat |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-01-01
|
Series: | Case Reports in Critical Care |
Online Access: | http://dx.doi.org/10.1155/2023/8530060 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Seizure as Presenting Symptom of Multisystem Inflammatory Syndrome in Children
by: Eleonora S. D’Ambrosio, et al.
Published: (2023-01-01) -
Unusual Presentation of Multisystemic Inflammatory Syndrome
by: Farah Alnoor Ebrahim, et al.
Published: (2022-01-01) -
Multisystem inflammatory syndrome in children with COVID-19 in a multitransfused patient
by: Swarnalata Das, et al.
Published: (2024-01-01) -
Serum HDL and their subfractions are impaired in multisystem inflammatory syndrome in children (MIS-C)
by: Antonietta Giannattasio, et al.
Published: (2025-01-01) -
Acute Abdomen as a Clinical Presentation of COVID-19-Associated Multisystem Inflammatory Syndrome in Children
by: Elmira Hajiesmaeil Memar, et al.
Published: (2024-01-01)